湖北农业科学 ›› 2020, Vol. 59 ›› Issue (23): 110-115.doi: 10.14088/j.cnki.issn0439-8114.2020.23.025

• 园艺·特产 • 上一篇    下一篇

基于网络药理学的天南星抗癌机制研究

郝爱平, 吴启康, 国会艳, 薛巨坤, 魏继承, 任如意   

  1. 牡丹江师范学院,黑龙江 牡丹江 157011
  • 收稿日期:2020-02-18 出版日期:2020-12-10 发布日期:2020-12-30
  • 作者简介:郝爱平(1979-),女,山东莘县人,副教授,硕士,主要从事北药天然成分生化与分子生物学研究,(电话)15604835344(电子信箱)swxhap@126.com
  • 基金资助:
    黑龙江省省属高等学校基本科研业务费科研项目(1353MSYYB011);黑龙江省大学生创新创业训练计划项目(201810233033)

Study on mechanism of Arisaema consanguineum anti-cancer based on network pharmacology

HAO Ai-ping, WU Qi-kang, GUO Hui-yan, XUE Ju-kun, WEI Ji-cheng, REN Ru-yi   

  1. Mudanjiang Normal University,Mudanjiang 157011,Heilongjiang,China
  • Received:2020-02-18 Online:2020-12-10 Published:2020-12-30

摘要: 基于网络药理学的方法探讨天南星(Arisaema consanguineum)的抗癌机制。利用TCMSP数据库、GeneCards数据库、Uniprot数据库查找天南星的活性成分和筛选抗癌靶点。通过Cytoscape3.7.1软件、STRING数据库、DAVID数据库、ImageGP软件建立化合物—抗癌靶点可视化网络图和抗癌靶点互作图,对靶点生物过程和通路进行分析。结果表明,共收集天南星主要抗癌活性成分松油醇、亚油酸等42个,作用于ADH1B、ADH1C等65个抗癌靶点,参与活性氧合成过程、腺体形态发生、急性炎症反应调控、细胞增殖等主要生物过程,调控神经活性配体—受体相互作用通路、癌症通路、P53信号通路、TNF信号通路、结直肠癌通路、小细胞肺癌通路、非小细胞肺癌通路、甲状腺癌通路、前列腺癌通路、细胞凋亡等通路,为今后天南星抗癌机制的深入研究提供了理论依据。

关键词: 网络药理学, 天南星(Arisaema consanguineum), 抗癌机制

Abstract: This study used the method of network pharmacology to study the anticancer mechanism of Arisaema consanguineum.The active components and targets of Arisaema consanguineum were searched using the TCMSP database,and these targets were uniformly named using the Uniprot database.Cytoscape 3.7.1 was used to establish a compound-anti-cancer target visualization network map,and the STRING database was used to construct the PPI network.Enrichment pathway analysis was performed using the DAVID website and the ImageGP database.Bioprocess analysis was performed using ClueGo software.The results showed that,a total of 42 anti-cancer active components and 65 anti-cancer targets were collected.The main anticancer active substances of Arisaema consanguineum include terpineol and linoleic acid.Important anti-cancer targets are ADH1B,ADH1C and the like.Arisaema consanguineum can show the multi-component,multi-target and multi-pathway anticancer function by by regulating TNF signaling pathways and p53 signaling pathways through biological processes such as participation in neuroactive ligand-receptor interactions and cancer processes.

Key words: network pharmacology, Arisaema consanguineum, anticancer mechanism

中图分类号: